[Palliative radiotherapy for symptomatic osseous metastases]

Area of Science:

• Oncology
• Radiotherapy
• Palliative Care

Background:

• Bone metastases are a common complication of advanced cancers, significantly impacting patient quality of life.
• Optimal radiotherapy schedules for symptomatic bone metastases remain debated, necessitating further clinical investigation.

Purpose of the Study:

• To evaluate the efficacy and outcomes of palliative radiotherapy for bone metastases in lung and breast carcinoma patients.
• To analyze the timing of bone metastasis diagnosis, pain relief rates, and long-term prognosis in these patient cohorts.

Main Methods:

• Retrospective analysis of 135 patients (72 lung, 63 breast carcinoma) treated with palliative radiotherapy between 1983 and 1992.
• Assessment of metastasis incidence, pain relief onset and rate, and patient survival post-radiotherapy.

Main Results:

• High rates of pain relief (81% lung, 85% breast) were observed, with rapid onset in about half of patients.
• Lung carcinoma presented metastases earlier (96% within 2 years), while breast carcinoma showed later onset (30% >5 years).
• Survival varied significantly, with one-third of breast cancer patients alive >2 years post-treatment, unlike most lung cancer patients.

Conclusions:

• Palliative radiotherapy is effective for pain management in bone metastases from both lung and breast cancers.
• Prolonged follow-up is essential due to the potential for late-onset metastases, particularly in breast cancer.
• Consideration of long-term radiation effects, like myelopathy, is critical, especially in breast cancer patients receiving palliative radiotherapy.